(Q38280833)

1 September 2017

1 reference

title

Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model (English)

1 reference

1 September 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Oscar Maiques

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Xavier Matias-Guiu Guia

6

object named as

Xavier Matias-Guiu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Núria Eritja

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Xavier Gonzalez-Tallada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Xavier Dolcet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

18 November 2014

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

77-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

31-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN function: how normal cells control it and tumour cells lose it

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Mutations of the human PTEN gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Accommodating haploinsufficient tumor suppressor genes in Knudson's model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN expression in non–small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Considerations when analyzing the methylation status of PTEN tumor suppressor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN1 is frequently mutated in primary endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Comprehensive miRNA profiling of surgically staged endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Prognostic significance of miR-205 in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

miR-19 is a key oncogenic component of mir-17-92

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-103 promotes colorectal cancer by targeting tumor suppressor DICER and PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Mmu-microRNA-200a overexpression leads to implantation defect by targeting phosphatase and tensin homolog in mouse uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Integrated genomic characterization of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Ultrastructural characterization of two new human endometrial carcinoma cell lines and normal human endometrial epithelial cells cultured on extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Epithelial organization, cell polarity and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Cell polarity and cancer--cell and tissue polarity as a non-canonical tumor suppressor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Polarity proteins in migration and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

The epithelial polarity program: machineries involved and their hijacking by cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Cell polarity in development and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Cell adhesion molecules as tumour suppressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

The Differentiated State of Normal and Malignant Cells or How to Define a “Normal” Cell in Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Advances in the formation, use and understanding of multi-cellular spheroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Scaffold-mediated symmetry breaking by Cdc42p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Phosphatidylserine is polarized and required for proper Cdc42 localization and for development of cell polarity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Culture of human endometrial cells under polarizing conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Growth of mouse endometrial luminal epithelial cells in vitro: functional integrity of the oestrogen receptor system and failure of oestrogen to induce proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Isolation and culture of human endometrial cells in a three-dimensional culture system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Ultrastructure of endometrial epithelial cells in a three-dimensional cell culture system for human implantation studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

A novel model of human implantation: 3D endometrium-like culture system to study attachment of human trophoblast (Jar) cell spheroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Pten is essential for embryonic development and tumour suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

A robust immunohistochemical assay for detecting PTEN expression in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Best practice for PTEN gene and protein assessment in anatomic pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Immunohistochemical markers for prognosis of anaplastic astrocytomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Loss of PTEN expression as a prognostic marker for tongue cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.11.001

10.1016/J.YMETH.2014.11.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25461816%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference